We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
-2.58%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.5B
AUM Growth
-$158M
Cap. Flow
-$58.5M
Cap. Flow %
-2.34%
Top 10 Hldgs %
19.33%
Holding
3,159
New
53
Increased
1,452
Reduced
739
Closed
54

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$11.9M
2
NVDA icon
NVIDIA
NVDA
+$11.4M
3
AMZN icon
Amazon
AMZN
+$6.65M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.34M
5
IVW icon
iShares S&P 500 Growth ETF
IVW
+$5.25M

Sector Composition

Rank Sector Weight
1 Technology 19.41%
2 Industrials 10.38%
3 Consumer Discretionary 9.74%
4 Financials 8.79%
5 Healthcare 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BV icon
2401
BrightView Holdings
BV
$1.08B
$27K ﹤0.01%
3,485
PTVE
2402
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$26.9K ﹤0.01%
3,313
ARQT icon
2403
Arcutis Biotherapeutics
ARQT
$3.25B
$26.9K ﹤0.01%
5,071
+825
+19% +$7.02K
MYPS icon
2404
PLAYSTUDIOS Inc
MYPS
$66.2M
$26.8K ﹤0.01%
8,439
+2,496
+42% +$9.9K
ITOS
2405
DELISTED
iTeos Therapeutics
ITOS
$26.8K ﹤0.01%
2,444
+839
+52% +$10.7K
SMBC icon
2406
Southern Missouri Bancorp
SMBC
$850M
$26.7K ﹤0.01%
690
GJAN icon
2407
FT Vest US Equity Moderate Buffer ETF January
GJAN
$439M
$26.6K ﹤0.01%
825
BLUE
2408
DELISTED
bluebird bio
BLUE
$26.4K ﹤0.01%
435
+103
+31% +$7.24K
ELVN icon
2409
Enliven Therapeutics
ELVN
$4.25B
$26.3K ﹤0.01%
1,928
FIP icon
2410
FTAI Infrastructure
FIP
$551M
$26.3K ﹤0.01%
8,174
WEAV icon
2411
Weave Communications
WEAV
$426M
$26.2K ﹤0.01%
3,215
+765
+31% +$7.75K
GCMG icon
2412
GCM Grosvenor
GCMG
$2.85B
$26.1K ﹤0.01%
3,365
REPX icon
2413
Riley Exploration Permian
REPX
$786M
$26.1K ﹤0.01%
821
HLLY icon
2414
Holley
HLLY
$362M
$25.8K ﹤0.01%
5,177
+1,320
+34% +$7.47K
HTB
2415
HomeTrust Bancshares
HTB
$837M
$25.8K ﹤0.01%
1,190
EBIX
2416
DELISTED
Ebix Inc
EBIX
$25.7K ﹤0.01%
2,606
+337
+15% +$6.55K
ALDX icon
2417
Aldeyra Therapeutics
ALDX
$86.9M
$25.7K ﹤0.01%
3,846
ALLO icon
2418
Allogene Therapeutics
ALLO
$683M
$25.7K ﹤0.01%
8,104
+2,067
+34% +$9.06K
UTMD icon
2419
Utah Medical Products
UTMD
$230M
$25.5K ﹤0.01%
296
TARO
2420
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$25.5K ﹤0.01%
675
TSP
2421
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$25.4K ﹤0.01%
16,290
+5,796
+55% +$10.1K
MVBF icon
2422
MVB Financial
MVBF
$397M
$25.3K ﹤0.01%
1,120
+380
+51% +$8.98K
LOCO icon
2423
El Pollo Loco
LOCO
$471M
$25.3K ﹤0.01%
2,823
+1,243
+79% +$12.1K
NWPX icon
2424
NWPX Infrastructure Inc
NWPX
$1.11B
$25.3K ﹤0.01%
837
LYEL icon
2425
Lyell Immunopharma
LYEL
$337M
$25.2K ﹤0.01%
856
+207
+32% +$9.83K

Similar funds

Ameritas Investment Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Ameritas Investment Partners held 3,159 positions worth $2.5B, down 5.9% from $2.66B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 3.4%. Ameritas Investment Partners opened 53 new positions and exited 54, leaving the 3,159-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q3 2023 buy was Equity Lifestyle Properties: 41,777 shares worth $2.66M.
  • Ameritas Investment Partners added most to Becton Dickinson in Q3 2023, an estimated $2.97M increase.
  • Ameritas Investment Partners's biggest Q3 2023 reduction was Microsoft, cutting an estimated $11.9M.
  • Ameritas Investment Partners fully exited Life Storage, Inc. in Q3 2023, selling an estimated $2.83M.
  • Ameritas Investment Partners's ten largest holdings make up 19% of its $2.5B portfolio in Q3 2023.
  • Ameritas Investment Partners opened 53 new positions and closed 54 in Q3 2023.
  • Ameritas Investment Partners's portfolio value fell 5.9% quarter-over-quarter to $2.5B.

Based on Ameritas Investment Partners's 13F filing for Q3 2023, filed 13 Nov 2023.